![Ashley Dombkowski](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ashley Dombkowski
Directeur/Membre du Conseil chez
HUDSON EXECUTIVE INVESTMENT CORP. III
Profil
Ashley L.
Dombkowski was the founder of Alladapt Immunotherapeutics, Inc., founded in 2018, serving as Chief Executive Officer & Secretary.
Dr. Dombkowski was the founder of iPierian, Inc., founded in 2007, serving as Director from 2009 to 2011.
Dr. Dombkowski was the founder of BEFORE Brands, Inc., founded in 2015, serving as Chief Executive Officer from 2015 to 2019.
Dr. Dombkowski currently holds the positions of President & Chief Executive Officer at Cellics Therapeutics, Inc., Treasurer & Director at USA Volleyball, and Independent Director at Hudson Executive Investment Corp.
III since 2021.
Former jobs include Director roles at Tercica, Inc., Neosil, Inc., Alnara Pharmaceuticals, Inc., Restore Medical, Inc. (2004–2006), Epizyme, Inc., and Rapt Therapeutics, Inc. (2025–2026); Managing Director at MPM BioImpact LLC (2000–2011) and Bay City Capital LLC; Chief Business Officer & Vice President-Operations at 23andMe, Inc. (2012–2013); Analyst at Tiger Management LLC (1999); Associate at RCM Capital Management LLC (1998).
Education includes a doctorate from William Marsh Rice University in 1997 and an undergraduate degree from Wellesley College in 1992.
Postes actifs de Ashley Dombkowski
| Sociétés | Poste | Début |
|---|---|---|
| HUDSON EXECUTIVE INVESTMENT CORP. III | Directeur/Membre du Conseil | 23/02/2021 |
USA Volleyball | Directeur/Membre du Conseil | - |
Cellics Therapeutics, Inc.
 Cellics Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops nanosponge technology for healthcare industry | Directeur Général | - |
Anciens postes connus de Ashley Dombkowski
| Sociétés | Poste | Fin |
|---|---|---|
| RAPT THERAPEUTICS, INC. | Directeur/Membre du Conseil | 03/03/2026 |
BEFORE Brands, Inc.
 BEFORE Brands, Inc. Food: Specialty/CandyConsumer Non-Durables Manufactures pediatric nutritional products for infants and toddlers | Directeur Général | 04/12/2019 |
23andMe, Inc.
 23andMe, Inc. Medical SpecialtiesHealth Technology Develops DNA analysis test kits | Directeur/Membre du Conseil | 02/10/2012 |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Membre du Comité d'Investissement | - |
Restore Medical, Inc.
 Restore Medical, Inc. Medical SpecialtiesHealth Technology Develops, manufactures & markets pillar palatal implant systems | Directeur/Membre du Conseil | 22/05/2006 |
Formation de Ashley Dombkowski
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
82
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Tiger Management LLC
 Tiger Management LLC Investment ManagersFinance Tiger Management employs a passive, multi-strategy, fund-of-fund investment approach. The firm also provides seed capital to other upcoming hedge fund managers. | Finance |
RCM Capital Management LLC
 RCM Capital Management LLC Investment ManagersFinance RCM Capital Management offers investment strategies that cover all market-caps and investment styles. The firm offers investment products that vary widely from regional and global strategies to multi-asset and structured products. They have particular expertise in: (1) regional/country equity strategies (2) global equity strategies (3) emerging markets equity strategies (4) thematic and sector strategies (5) alpha extension strategies (6) multi-asset absolute return strategies and (7) structured products. RCM's investment philosophy is based on proprietary sector-based fundamental research. Though not limited by sector, RCM tends to invest in the stocks of companies in the electronic technology, technology services and health technology sectors. The firm invests globally, across all market-caps. RCM maintains a medium turnover rate. | Finance |
Tercica, Inc.
 Tercica, Inc. Pharmaceuticals: MajorHealth Technology Develops new therapeutics for endocrine system disorders | Health Technology |
Neosil, Inc.
 Neosil, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Alnara Pharmaceuticals, Inc.
 Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics for the treatment of metabolic diseases | Health Technology |
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
Rice University
 Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wellesley College
 Wellesley College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Restore Medical, Inc.
Restore Medical, Inc. Medical SpecialtiesHealth Technology Develops, manufactures & markets pillar palatal implant systems | Health Technology |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital invests in public and private companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and later stage capital transactions. The firm makes co-investments. It acts as a lead investor and takes a seat on the board of directors. | Finance |
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology Develops DNA analysis test kits | Health Technology |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
USA Volleyball | Consumer Services |
iPierian, Inc.
 iPierian, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Cellics Therapeutics, Inc.
Cellics Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops nanosponge technology for healthcare industry | Commercial Services |
Rapt Therapeutics, Inc.
 Rapt Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oral small molecule therapies for patients | Health Technology |
BEFORE Brands, Inc.
BEFORE Brands, Inc. Food: Specialty/CandyConsumer Non-Durables Manufactures pediatric nutritional products for infants and toddlers | Consumer Non-Durables |
Alladapt Immunotherapeutics, Inc.
 Alladapt Immunotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics targeting food allergy | Health Technology |
Hudson Executive Investment Corp. III
 Hudson Executive Investment Corp. III Financial ConglomeratesFinance Operates as a blank check company | Finance |
